Historical Stock Price
ETFs Holding ABUS »    ABUS Split History »
Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
06/14/2021 $3.30 $3.43 $3.30 $3.40 1.10M
06/15/2021 $3.38 $3.40 $3.17 $3.18 1.05M
06/16/2021 $3.16 $3.22 $3.08 $3.22 1.61M
06/17/2021 $3.18 $3.35 $3.18 $3.26 1.03M
06/18/2021 $3.23 $3.29 $3.16 $3.25 1.31M
Arbutus Biopharma is a biopharmaceutical company focused on developing a cure for patients suffering from chronic hepatitis B infection, a disease of the liver caused by the hepatitis B virus (HBV). Co. is developing a product pipeline consisting of multiple drug candidates with complementary mechanisms of action. Co.'s pipeline includes: AB-729, a subcutaneously-delivered RNA interference therapeutic product candidate; AB-836, a capsid inhibitor product candidate; and other compounds early in the development process, including back-up capsid inhibitors, oral HBV RNA destabilizers and compounds that inhibit PD-L1.
ABUS historical stock prices picture
Arbutus Biopharma (ABUS) has the following price history information. Looking back at ABUS historical stock prices for the last five trading days, on June 14, 2021, ABUS opened at $3.30, traded as high as $3.43 and as low as $3.30, and closed at $3.40. Trading volume was a total of 1.10M shares. On June 15, 2021, ABUS opened at $3.38, traded as high as $3.40 and as low as $3.17, and closed at $3.18. Trading volume was a total of 1.05M shares. On June 16, 2021, ABUS opened at $3.16, traded as high as $3.22 and as low as $3.08, and closed at $3.22. Trading volume was a total of 1.61M shares. On June 17, 2021, ABUS opened at $3.18, traded as high as $3.35 and as low as $3.18, and closed at $3.26. Trading volume was a total of 1.03M shares. On June 18, 2021, ABUS opened at $3.23, traded as high as $3.29 and as low as $3.16, and closed at $3.25. Trading volume was a total of 1.31M shares.

ABUS Historical Stock Prices By Date:

ABUS historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Arbutus Biopharma shares, starting with a $10,000 purchase of ABUS, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 06/21/2011
End date: 06/18/2021
Start price/share: $2.63
End price/share: $3.25
Dividends collected/share: $0.00
Total return: 23.57%
Average Annual Total Return: 2.14%
Starting investment: $10,000.00
Ending investment: $12,358.29
Years: 10.00
Date Close
06/14/2021$3.40
06/15/2021$3.18
06/16/2021$3.22
06/17/2021$3.26
06/18/2021$3.25

ABUS Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2021, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.